All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Looking to beef up its diabetes pipeline, pharma giant Merck & Co. Inc. is acquiring insulin maker SmartCells Inc. in a deal potentially worth $500 million, including an undisclosed up-front payment.